Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.
about
HSV-2: in pursuit of a vaccineThe challenges and opportunities for the development of a T-cell epitope-based herpes simplex vaccineA herpes simplex virus 2 (HSV-2) glycoprotein D-expressing nonreplicating dominant-negative HSV-2 virus vaccine is superior to a gD2 subunit vaccine against HSV-2 genital infection in guinea pigsGlobal sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging.Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.Pan-HSV-2 IgG antibody in vaccinated mice and guinea pigs correlates with protection against herpes simplex virus 2.Liposomes as vaccine delivery systems: a review of the recent advances.Prospects and perspectives for development of a vaccine against herpes simplex virus infections.Breaking B and T cell tolerance using cationic lipid--DNA complexes (CLDC) as a vaccine adjuvant with hepatitis B virus (HBV) surface antigen in transgenic mice expressing HBVCavia porcellus as a model for experimental infection by Trypanosoma cruziHigher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.Herpes Simplex Vaccines: Prospects of Live-attenuated HSV Vaccines to Combat Genital and Ocular infections.Sensing herpes: more than toll.Cationic liposomal vaccine adjuvants in animal challenge models: overview and current clinical status.Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.HSV-1-induced chemokine expression via IFI16-dependent and IFI16-independent pathways in human monocyte-derived macrophages.
P2860
Q22306291-805D029E-B92A-4DBD-8A5E-FCDEBF0B1A4AQ27021292-6BFB33F4-ED93-4DE4-A7C2-C53C5C3253E6Q33825931-C0AEA876-0706-4A47-8D70-1A1AD5045405Q33834821-44D4D2BE-34D9-4E66-B642-3E51A363E525Q34057952-B85FBE5F-8F63-4BC2-86BE-462F66ED14C6Q34350019-90F6A688-D934-47E9-841E-DE5A26120948Q34418761-DFF6D558-2D80-4B16-AAF1-398A73133C94Q34431547-D9E9D1CC-A977-4BBD-B117-D98B4C3ED46CQ35052956-BFDF2D69-AE4F-41AF-B9D8-392B7A1B61FAQ35069952-F6854F7D-DDFA-469B-92C5-AD7272951700Q35866976-CF7E9E9A-EDD9-474D-AEF4-466B2D597BFFQ36824210-BB0C5660-4676-4A7C-AD96-9DC832998EFBQ37948677-88C305FC-EBFC-4962-A88C-5F7506E96061Q38028994-256E23D9-8425-40DE-939B-B349711BAABCQ38212516-394E016B-3218-41F4-94F2-F62723A3232FQ38241377-EFD1E2EB-7428-48EB-8F73-FC9A3686C7D0Q42412053-AF767304-A359-4708-94FD-C39DB0056B70
P2860
Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Effects of herpes simplex viru ...... s infection in the guinea pig.
@ast
Effects of herpes simplex viru ...... s infection in the guinea pig.
@en
Effects of herpes simplex viru ...... s infection in the guinea pig.
@nl
type
label
Effects of herpes simplex viru ...... s infection in the guinea pig.
@ast
Effects of herpes simplex viru ...... s infection in the guinea pig.
@en
Effects of herpes simplex viru ...... s infection in the guinea pig.
@nl
prefLabel
Effects of herpes simplex viru ...... s infection in the guinea pig.
@ast
Effects of herpes simplex viru ...... s infection in the guinea pig.
@en
Effects of herpes simplex viru ...... s infection in the guinea pig.
@nl
P2093
P2860
P1433
P1476
Effects of herpes simplex viru ...... s infection in the guinea pig.
@en
P2093
David I Bernstein
Fernando J Bravo
Gary H Cohen
Jeffrey Fairman
Jennifer R Clark
Julie D Earwood
Rhonda D Cardin
P2860
P304
P356
10.1016/J.VACCINE.2011.01.005
P407
P577
2011-01-14T00:00:00Z